Four papers focused on RA and explored the correlation between serum and salivary antibodies in discriminating patients from controls (including HC and subjects “at-risk” for RA based on familial RA and/or serum anticitrullinated protein antibody (ACPA) positivity) [27,30], the association between antibodies and periodontitis [29], and that between autoantibody specificity and titer and disease activity [28]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.